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Primary systemic amyloidosis (PSA) is one of systemic amyloidosis, characterized by clonal plasma cell disorder. The
disease is rare and with high fatality. Signs and symptoms of PSA are various and complex, which depend on the
organs involved. Here we report a case in which the patient initially suffered from gastrointestinal symptoms.
Gradually periorbital purpura, skin fragility, and subsequent petechiae, ecchymoses and sclerosis of the distal limbs,
appeared. Biopsy of his palmar skin showed scleroderma-like changes. However, histopathology of the petechiae
lesion on forehead with Crystal Violet Staining prompted deposition of amyloid; gastric mucosal biopsy with Congo
Red staining was also positive, which made clear the diagnosis of PSA. Bone marrow biopsy and serum
immunofixation electrophoresis (IFE) revealed plasmacytosis and M proteinemia. Other examinations were
performed to assess the function of organs. PSA was challenging due to the initial atypical clinical presentation and
absence of biopsy with special staining. The case demonstrates that PSA should be considered in patients with
multisystemic symptoms and biopsy with Congo Red staining should be performed to exclusively diagnose amyloidosis.
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M proteinemiaBackground
Primary systemic amyloidosis (PSA), also called Lubarsch-
Pick disease, is a rare, complex and protean disease. Cur-
rently, it is a mortal disease without any effective therapy,
and its median survival time is approximatedly 13 months
[1]. In the US, the incidence of PSA is estimated to be ap-
proximately 1275 to 3200 new cases per year [2]. Here we
report a case of PSA initially presenting with gastrointes-
tinal symptoms. However, it had been misdiagnosed of
scleroderma and recurrent chronic gastritis.Case presentation
A 47-year-old male presented with recurrent dizziness,
generalized weakness, easy fatiguablility, accompanied
with discontinuous abdominal pain, dyspepsia and con-
stipation for six years. He had been examined with gas-
troendoscope and magnetic resonance imaging (MRI) of* Correspondence: mao_yp@163.com
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be identified. Gradually the skin of his fingers and toes
became sclerotic. At the same time, multiple, non-itchy
petechiae, purpura and ecchymoses lesions can been
found around the eyelids, as well as on the tongue, cheek,
neck and the higher chest wall bilaterally (Fig. 1a-f). Bi-
opsy of his palmar skin showed scleroderma-like changes.
He had been treated as chronic gastritis and scleroderma.
However, his symptoms were aggressive and he came to
our hospital. His blood examinations and stool anlysis
were found within normal limits. Serum amyloid A pro-
tein (SAA) was also negative. Skin biopsy of the forehead
lesion showed pink amorphous, eosinophilic fissured
masses in the dermis with Haemotoxylin & Eosin staining
(Fig. 2). Moreover, it showed purple amorphous fissured
masses in dermis with Crystal Violet staining (Fig. 3),
which prompted the deposition of amyloid. Besides, histo-
pathologic examination of the gastric mucosal revealed
the extensive deposition of amyloid in the gland stomach
tissues and vessel wall. The tissue displayed orange–red
color with Congo Red staining under the light microscopyistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 (a-d) Petechiae, purpura distributed on the forehead, neck, cheek and tongue; (e-f) Digital skin changed as scleroderma
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gence under polarized light (Fig. 5). Moreover, it showed
pale orange–red after potassium permanganate pretreat-
ment (Fig. 6), consistent with the diagnosis of PSA (light
chains, AL). Bone marrow biopsy showed a proliferation
of 14 % mature plasma cells. Proteinuria electrophoresis
showed the presence of Bence-Jones protein. Immunofixa-
tion of the concentrated urine detected light chains of
LAM-type. Serum and urine immunofixation electrophor-
esis (IFE) were both positive for monoclonal protein. Ana-
lysis of the results showed M proteinemia of IgA-LAM.
Quantitative immunoglobulin studies showed a serum
IgG value of 3.82 g/l (normal 7–16 g/l), IgA 2.44 g/l (0.7–
4 g/l) and IgM 0.20 g/l (0.5–2.20 g/l). Surprisingly,Fig. 2 Microphotograph showed pink eosinophilic homogenous
material in the dermis, H&E X 40according to the whole abdomen Computed Tomography
and ultrasound, we found the patient relied on a solitary
right kidney as the left residue was found in the pelvic cav-
ity without any sign of blood flow. Urinalysis showed oc-
cult blood and protein quantitative testing for urine
protein was 4.1 g/24 h, and blood creatinine and urea ni-
trogen were in the high level. He was treated with prednis-
one (40 mg/d), thalidomide, colchicine tablets and gastric
mucosa protective drugs. After a month, skin lesion and
digestive symptoms improved, but he left hospital because
of economic cause.
Discussion
PSA is a clonal plasma cell disorder, including the pro-
duction, aggregation, polymerization, fibril formation
and finally extracellular deposition in various organs ofFig. 3 Skin biopsy with crystal violet stain(X 40) showed bright
purple amorphous fissured masses in the dermis
Fig. 4 Histopathology of gastric mucosa showed orange-red positivity
with Congo Red staining (X 40)
Fig. 6 Histopathology of gastric mucosa with Congo Red staining
showed pale orange–red after potassium permanganate pretreatment
(Microphotograph X40)
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function and death [3]. Symptoms and signs of it are
various and complex, which depend on the organs in-
volved. In the early state, patients may present some
non-specific clinical symptoms, such fatigue, weight loss,
paresthesias and syncopal attacks, just as the patient in
this case. Guadually, intracutaneous hemorrhage mani-
fests in the form of petechiae, purpura and ecchymoses
due to infiltration of blood vessel walls by amyloid de-
posits, which are the most common skin lesions. At the
same time, symptoms of the affected organs can appear,
manifesting multisystem symptoms. In some cases, skin
lesions can be atypical, such as multiple papules [4] in-
stead of petechiae and ecchymoses on head and face. InFig. 5 Histopathology of gastric mucosa with Congo Red staining
showed characteristic apple-green birefringence under polarized
light (X10)other words, insufficient understanding of the rash is
easy to lead to misdiagnosis and delay of treatments.
Firstly, in order to make correct diagnosis of the dis-
ease, biopsy with Congo Red staining of the affected
organ is significant. Routine pathological examination
without the special staining always leads to misdiagnosis
[5–7]. As in the case, gastrointestinalscope only pre-
sented the feature of chronic erosive gastritis without
Congo Red staining. Secondly, distinguishing the type of
amyloid is important for treatments. Amyloidosis can be
classified clinically into systemic (generalized), with in-
volvement of several organ systems, and organ-limited
(localized), in which deposits are limited to a single
organ such as the skin (Table 1) [1]. In the systemic
amyloidosis, there are primary, secondary and heredofa-
milial amyloidosis. PSA often accompany with multiple
myeloma, which can produce light chain protein as one
of the precursor protein of amyloidosis. In this case,
treatment of the multiple myeloma is most important to
the disease. Thirdly, it is necessary to completely check
on the function of important organs, as sedimentation of
amyloid can involve any organs. Kidney is the most sen-
sitive organ (74 %) in PSA, then the heart (60 %), liver
(27 %) and peripheral nervous system (22 %), autonomic
nervous system (18 %) [8]. There is about 69 % of the
patients with two organs involvement at least [8].
Gastrointestinal amyloidosis is less common in primary
systemic amyloidosis, with only 1 % incidence in a retro-
spective review from the Mayo Clinic, Rochester, Min-
nessota, United States [9]. Many endoscopic features of
AL amyloidosis are not specific to the disease. Findings
include thickened folds, erosions, ulcerations, friability,
edema and submucosal hematoma [10–15]. In other
words, it is easy to misdiagnosis without biopsy of the
Table 1 Clinical classification of amyloidosis
Clinical classification of amyloidosis including
Systemic amyloidosis
Primary systemic amyloidosis(AL> > AH amyloid protein)
Plasma cell dyscrasias (more common)
Multiple myeloma-associated
Secondary systemic amyloidosis (reactive;AA amyloid protein)
Chronic inflammation (e.g.rheumatoid arthritis)
Chronic infection (e.g.tuberculosis)





Primary:macular, lichen, biphasic, dyschromic, nodular
Secondary:within skin tumors
Endocrine
Medullary carcinoma of the thyroid, insulinoma, type 2 diabetes
Cerebral
Alzheimer 's disease
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symptoms and signs in amyloidosis is variable such as
isolated proteinuria, nephrotic syndrome, hypertension,
hypotension, renal insufficiency [16]. In this case, we did
not practice the renal biopsy, as it has been reported
that patients of amyloidosis resulted in serious bleeding
over renal biopsy centesis [17]. Moreover, examinations
revealed that the patient relied on a solitary right kidney
as the left one was congenital dysplasia.Conclusions
In summary, clinical manifestations of PSA are diverse
and nonspecific. It should be considered in patients with
skin lesion such as petechiae, purpura and ecchymoses,
especially accompanying with multisystemic symptoms.
Biopsy of lesion with Congo Red staining is of diagnostic
significance.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images.
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